Stock Events

Ultragenyx Pharmaceutical (RARE.MX) Q2 2021 Earnings

4MayConfirmed
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-40.99
-25.47
-9.95
5.58

Details

Expected EPS
-26.857887
Actual EPS
-40.99361699999999
Surprise EPS
-14.14
Surprise Percent
+52.63%

Description

Ultragenyx Pharmaceutical (RARE.MX) has reported earnings of -40.99361699999999 per share for Q2 2021.

0 Comments

Share your thoughts